Lannett Co Inc (LCI)
(Delayed Data from NYSE)
$8.54 USD
+0.70 (8.93%)
Updated May 3, 2019 04:00 PM ET
After-Market: $8.54 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
[LCI]
Reports for Purchase
Showing records 41 - 60 ( 421 total )
Industry: Medical - Drugs
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Industry: Medical - Drugs
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Industry: Medical - Drugs
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Industry: Medical - Drugs
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Industry: Medical - Drugs
FY2Q18 Recap - Weak top line, Strong bottom line
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Industry: Medical - Drugs
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Industry: Medical - Drugs
4Q17 Recap - Few Surprises Given Preannouncement
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Industry: Medical - Drugs
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Industry: Medical - Drugs
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Industry: Medical - Drugs
FY2Q17 Solid - Levo Continues to Carry the Load
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S